Atlas Concussion Testing was founded in order to provide an innovative and new method of managing mild traumatic brain injuries with biomarkers. The centerpiece of Atlas Concussion Testing is the Blood Brain Barrier Permeability Test, also referred to as the Array 20, provided exclusively by Cyrex Labs. As everyone who will be in attendance at the Concussion Health Summit already knows, research in the field of objective biomarkers for diagnosing concussions is quickly becoming a very important tool in concussion management. More important than diagnosing the presence of a concussion is determining when a brain has fully healed from a concussion. With the Array 20 from Cyrex Labs and the implementation protocols established by Atlas Concussion Testing, that is now possible.
The Array 20 is scientifically supported by the research that went into its development. The relationship between the structures of the blood brain barrier and the neuroanatomy and neurophysiology of the brain and related tissues is paramount to understanding the cascade of events following mTBI. Most importantly, immune responses both within the brain and from the body’s immune system outside of the brain are the key to diagnosing and managing concussions with the Array 20. This blood test can objectively confirm the diagnosis of a concussion, but even more importantly, it can tell physicians that the blood brain barrier is healed and it is SAFE for athletes to return to contact sports. There is less risk of Second Impact Syndrome and no more guesswork involved in returning concussed athletes too soon when proper implementation of the Array 20 is at the center of a return to play protocol.
As many of us know, Second Impact Syndrome has been deadly in an unfortunate number of circumstances. This is where Atlas Concussion Testing’s implementation protocols of the Array 20 are so critical. When using definitive biomarkers as a diagnostic tool, it obviously is easier to determine the presence of a concussion. This is something that can be done using a variety of different resources. So what separates Atlas Concussion Testing and the Array 20 from everything else? It is the power to diagnose not the presence, but the absence of a concussion, objectively. What does this mean? This means that you will never have to worry about returning athletes too soon from a concussion. The possibility of the Second Impact Syndrome is virtually eliminated. The ambiguous nature of concussion management can be solved by implementing the tool of definitive and objective biomarkers into the return-to-play concussion protocol. The use of such a powerful tool is why our company’s implementation protocols combined with Cyrex’s Array 20 is such an important and critical piece in the return-to-play process from a concussion.
Clearly, the most important piece of concussion management for us is making sure that every single concussed athlete returns to contact fully healed. In order to get to this point, it is also important to initiate treatment as soon as possible. We have developed what we like to call the C1 Treatment Protocol when it comes to managing concussions. The C1 Protocol is designed to reduce neuroinflammation and heal the blood brain barrier. We target the metabolic pathways that are involved with immunoexcitotoxicity following mTBI’s. Utilizing specific combinations of botanicals, compounds and cofactors in conjunction with an anti-inflammatory diet we have been able to return athletes to play in a fraction of the time that rest alone can accomplish. The C1 Protocol is a trademarked treatment program that also provides nutritional strategies that can affect the metabolic dysfunction that occurs following mTBI/concussion. The C1 Protocol may be incorporated into any current concussion management program, seamlessly. Atlas Concussion Testing does not wish to replace your current testing and treatment program, just enhance it with attention to the metabolic components.
Concussion Health’s agenda to “set the gold standard in collaboration, education and management of concussions" resonated with our company on a personal level and was the #1 reason why we decided to attend the Summit. Our goal as a company is to provide the very best and the very safest possible concussion management protocol to each athletic organization in the country. With the Array 20 at the centerpiece of our concussion management strategy, we feel that we are capable of contributing to the gold standard. We look forward to being a sponsor at the Concussion Health Summit and we hope that you all enjoy Dr. Alden’s presentation during the sponsor spotlight. We cannot wait to meet all of you!
Thank you to Atlas Concussion Testing for contributing to our Summit Sponsor Showcase! We look forward to seeing you at The Concussion Health Summit.
Register today to attend the Summit and join the conversation discussing the latest knowledge and technology regarding concussion management. Click here to register.
Concussion Health Blog
Thanks for stopping by! Leave a comment. We want to hear from you.